Bristol-Myers Squibb Company (BMY) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/11/23
Big Institutions Grab ‘Strong Buy' Dividend Stocks in a Sector Not Totally Driven by AI24/7 Wall Street • 09/11/23
Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung CancerBusiness Wire • 09/11/23
Bristol Myers Squibb's Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 StudyBusiness Wire • 09/09/23
Bristol Myers Squibb Celebrates a Decade of Its Coast 2 Coast 4 Cancer Cross-Country Bike Ride in Support of the V Foundation for Cancer ResearchBusiness Wire • 09/07/23
Bristol Myers Squibb to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceBusiness Wire • 09/01/23
Medicare's First Price Negotiation List Targets Expensive Drugs (Revised)Zacks Investment Research • 08/31/23
Medicare drug price negotiations may have a muted impact on drugmakers in the near termCNBC • 08/30/23
U.S. FDA Approves Bristol Myers Squibb's Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require TransfusionsBusiness Wire • 08/29/23
Long-Term Follow-Up Data from Two Phase 3 Studies of CAMZYOS® (mavacamten) Demonstrate Consistent and Durable Response in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)Business Wire • 08/28/23
Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership Program to Evaluate Automated Manufacturing of CAR-T Cell Therapy on the Cell Shuttle PlatformPRNewsWire • 08/28/23
Retrospective Observational Study Assessing Real-World Clinical Impact of Switching or Continuing Eliquis® or Rivaroxaban Presented at the European Society of Cardiology (ESC) Congress 2023Business Wire • 08/25/23
Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value PropositionSeeking Alpha • 08/24/23